title: Synthetic lethal hubs associated with vincristine resistant neuroblastoma.
authors.affiliation: Emergentec Biodevelopment GmbH, Gersthofer Strasse 29-31, 1180 Vienna, Austria.
authors.forename: Raul
authors.initials: R
authors.lastname: Fechete
authors.forename: Susanne
authors.initials: S
authors.lastname: Barth
authors.forename: Tsviya
authors.initials: T
authors.lastname: Olender
authors.forename: Andreea
authors.initials: A
authors.lastname: Munteanu
authors.forename: Andreas
authors.initials: A
authors.lastname: Bernthaler
authors.forename: Aron
authors.initials: A
authors.lastname: Inger
authors.forename: Paul
authors.initials: P
authors.lastname: Perco
authors.forename: Arno
authors.initials: A
authors.lastname: Lukas
authors.forename: Doron
authors.initials: D
authors.lastname: Lancet
authors.forename: Jindrich
authors.initials: J
authors.lastname: Cinatl
authors.forename: Martin
authors.initials: M
authors.lastname: Michaelis
authors.forename: Bernd
authors.initials: B
authors.lastname: Mayer
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm / Q000235:genetics / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism*; D038941:Polypyrimidine Tract-Binding Protein / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; C504334:PTBP2 protein, human; D038941:Polypyrimidine Tract-Binding Protein; D014750:Vincristine